648 related articles for article (PubMed ID: 11567967)
1. Uveal tumour resection.
Char DH; Miller T; Crawford JB
Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
[TBL] [Abstract][Full Text] [Related]
2. Eye-wall resection.
Char DH; Miller T; Crawford JB
Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
[TBL] [Abstract][Full Text] [Related]
3. Internal eye wall resection of uveal tumors: long-term evaluation.
Moreira CA; Moreira Neto CA
Arq Bras Oftalmol; 2015; 78(1):47-9. PubMed ID: 25714539
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of visual outcome after local resection of choroidal melanoma.
Damato BE; Paul J; Foulds WS
Br J Ophthalmol; 1993 Oct; 77(10):616-23. PubMed ID: 8218028
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
7. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
Seregard S; Lundell G; Lax I; af Trampe E; Kock E
Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
[TBL] [Abstract][Full Text] [Related]
8. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
9. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
[TBL] [Abstract][Full Text] [Related]
10. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
[TBL] [Abstract][Full Text] [Related]
11. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
[TBL] [Abstract][Full Text] [Related]
12. Endoresection of large uveal melanomas: clinical results in a consecutive series of 200 cases.
Biewald E; Lautner H; Gök M; Horstmann GA; Sauerwein W; Flühs D; Bornfeld N
Br J Ophthalmol; 2017 Feb; 101(2):204-208. PubMed ID: 27121095
[TBL] [Abstract][Full Text] [Related]
13. [Trans-scleral resection of the ciliary body and choroidal melanoma].
Romanowska-Dixon B; Starzycka M; Pogrzebielski A
Klin Oczna; 2000; 102(5):323-6. PubMed ID: 11286105
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
17. Vitreoretinal Surgery in the Prevention and Treatment of Toxic Tumour Syndrome in Uveal Melanoma: A Systematic Review.
Romano MR; Catania F; Confalonieri F; Zollet P; Allegrini D; Sergenti J; Lanza FB; Ferrara M; Angi M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576231
[TBL] [Abstract][Full Text] [Related]
18. Episcleral plaque radiotherapy for uveal melanoma.
Giblin ME; Shields JA; Augsburger JJ; Brady LW
Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581
[TBL] [Abstract][Full Text] [Related]
19. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for metastatic uveal melanoma after trans-scleral local resection.
Damato BE; Paul J; Foulds WS
Br J Ophthalmol; 1996 Feb; 80(2):109-16. PubMed ID: 8814739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
